- Home
- GDTC vs OKYO Comparison
GDTC vs OKYO Comparison
Compare GDTC & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- OKYO
- Stock Information
- Founded
- GDTC 2018
- OKYO 2007
- Country
- GDTC Singapore
- OKYO United Kingdom
- Employees
- GDTC N/A
- OKYO N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GDTC Health Care
- OKYO Health Care
- Exchange
- GDTC Nasdaq
- OKYO Nasdaq
- Market Cap
- GDTC 33.4M
- OKYO 36.2M
- IPO Year
- GDTC 2023
- OKYO 2022
- Fundamental
- Price
- GDTC $2.37
- OKYO $1.09
- Analyst Decision
- GDTC Buy
- OKYO Strong Buy
- Analyst Count
- GDTC 1
- OKYO 1
- Target Price
- GDTC $5.00
- OKYO $7.00
- AVG Volume (30 Days)
- GDTC 24.9K
- OKYO 24.1K
- Earning Date
- GDTC 01-01-0001
- OKYO 12-27-2024
- Dividend Yield
- GDTC N/A
- OKYO N/A
- EPS Growth
- GDTC N/A
- OKYO N/A
- EPS
- GDTC N/A
- OKYO N/A
- Revenue
- GDTC $330,254.00
- OKYO N/A
- Revenue This Year
- GDTC $14.71
- OKYO N/A
- Revenue Next Year
- GDTC N/A
- OKYO N/A
- P/E Ratio
- GDTC N/A
- OKYO N/A
- Revenue Growth
- GDTC N/A
- OKYO N/A
- 52 Week Low
- GDTC $1.20
- OKYO $0.81
- 52 Week High
- GDTC $5.50
- OKYO $2.01
- Technical
- Relative Strength Index (RSI)
- GDTC 45.29
- OKYO 57.32
- Support Level
- GDTC $2.43
- OKYO $1.02
- Resistance Level
- GDTC $3.00
- OKYO $1.13
- Average True Range (ATR)
- GDTC 0.41
- OKYO 0.05
- MACD
- GDTC -0.03
- OKYO 0.01
- Stochastic Oscillator
- GDTC 21.60
- OKYO 74.58
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.